Back to Show
PBS News Hour
Should drug companies profit from coronavirus vaccine?
COVID-19 vaccine development continues to be the subject of political jostling, with President Trump contradicting top U.S. health officials regarding timeline and efficacy. The Centers for Disease Control and Prevention say they expect to distribute vaccines publicly at no cost to the patient. But what will the government pay, and how much could drug companies profit? Paul Solman reports.
Support Provided By
57:46
Israel's Prime Minister says the intense phase of the war in Gaza will end soon as Israel and the U.S. argue over weapons deliveries.
57:46
After Claudia Sheinbaum becomes the first woman to win Mexico's presidential election, a look at what that means for U.S. relations.
26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.
56:45
A court rejects Trump's claim of immunity with major implications for his election interference case.
26:36
Why a record number of people across America are experiencing homelessness this holiday season.
24:44
How some cities are testing no-strings-attached payment programs as a way to help lower-income residents get a leg up.
56:45
Hunter Biden's plea deal unravels over concerns about whether future charges can be brought against the president's son.
56:45
Floodwaters rage and dangerous heat waves grow worse, posing serious risks to millions of Americans.
56:44
NATO leaders kick off a multi-nation summit with Ukraine seeking a path to join the expanding alliance.